Post Marketing Information DHCPL 30/11/2017 Important findings from a supplementary exploratory study on Dengvaxia® to assess long term safety and efficacy of Dengvaxia® from Phase IIb/III studies PEM 13/12/2022 Physician Educational Material Dengvaxia™ PMG 27/04/2023 Patient Medication Guide Dengvaxia™
SUBCUTANEOUS Select a brand starting with the letter: D DENGVAXIA, POWDER AND SOLVENT FOR SUSPENSION FOR INJECTION [SIN15096P]